Literature DB >> 35353001

The Murine Neuronal Receptor NgR1 Is Dispensable for Reovirus Pathogenesis.

Pavithra Aravamudhan1,2, Camila Guzman-Cardozo1,2, Kelly Urbanek1,2, Olivia L Welsh1,2, Jennifer L Konopka-Anstadt3, Danica M Sutherland1,2, Terence S Dermody1,2,4.   

Abstract

Engagement of host receptors is essential for viruses to enter target cells and initiate infection. Expression patterns of receptors in turn dictate host range, tissue tropism, and disease pathogenesis during infection. Mammalian orthoreovirus (reovirus) displays serotype-dependent patterns of tropism in the murine central nervous system (CNS) that are dictated by the viral attachment protein σ1. However, the receptor that mediates reovirus CNS tropism is unknown. Two proteinaceous receptors have been identified for reovirus, junctional adhesion molecule A (JAM-A) and Nogo-66 receptor 1 (NgR1). Engagement of JAM-A is required for reovirus hematogenous dissemination but is dispensable for neural spread and infection of the CNS. To determine whether NgR1 functions in reovirus neuropathogenesis, we compared virus replication and disease in wild-type (WT) and NgR1-/- mice. Genetic ablation of NgR1 did not alter reovirus replication in the intestine or transmission to the brain following peroral inoculation. Viral titers in neural tissues following intramuscular inoculation, which provides access to neural dissemination routes, also were comparable in WT and NgR1-/- mice, suggesting that NgR1 is dispensable for reovirus neural spread to the CNS. The absence of NgR1 also did not alter reovirus replication, neural tropism, and virulence following direct intracranial inoculation. In agreement with these findings, we found that the human but not the murine homolog of NgR1 functions as a receptor and confers efficient reovirus binding and infection of nonsusceptible cells in vitro. Thus, neither JAM-A nor NgR1 is required for reovirus CNS tropism in mice, suggesting that other unidentified receptors support this function. IMPORTANCE Viruses engage diverse molecules on host cell surfaces to navigate barriers, gain cell entry, and establish infection. Despite discovery of several reovirus receptors, host factors responsible for reovirus neurotropism are unknown. Human NgR1 functions as a reovirus receptor in vitro and is expressed in CNS neurons in a pattern overlapping reovirus tropism. We used mice lacking NgR1 to test whether NgR1 functions as a reovirus neural receptor. Following different routes of inoculation, we found that murine NgR1 is dispensable for reovirus dissemination to the CNS, tropism and replication in the brain, and resultant disease. Concordantly, expression of human but not murine NgR1 confers reovirus binding and infection of nonsusceptible cells in vitro. These results highlight species-specific use of alternate receptors by reovirus. A detailed understanding of species- and tissue-specific factors that dictate viral tropism will inform development of antiviral interventions and targeted gene delivery and therapeutic viral vectors.

Entities:  

Keywords:  JAM-A; NgR1; host range; neuropathogenesis; reovirus; viral tropism

Mesh:

Substances:

Year:  2022        PMID: 35353001      PMCID: PMC9044964          DOI: 10.1128/jvi.00055-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  52 in total

Review 1.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

2.  The Nogo receptor NgR1 mediates infection by mammalian reovirus.

Authors:  Jennifer L Konopka-Anstadt; Bernardo A Mainou; Danica M Sutherland; Yuichi Sekine; Stephen M Strittmatter; Terence S Dermody
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

3.  Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).

Authors:  H W Virgin; R Bassel-Duby; B N Fields; K L Tyler
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

Review 4.  The oncolytic virus, pelareorep, as a novel anticancer agent: a review.

Authors:  Romit Chakrabarty; Hue Tran; Giovanni Selvaggi; Allison Hagerman; Brad Thompson; Matt Coffey
Journal:  Invest New Drugs       Date:  2015-02-19       Impact factor: 3.850

5.  Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition.

Authors:  Xiaolin L He; J Fernando Bazan; Gerry McDermott; Jong Bae Park; Kevin Wang; Marc Tessier-Lavigne; Zhigang He; K Christopher Garcia
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

6.  Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis.

Authors:  Kenneth L Tyler; Erik S Barton; Maria L Ibach; Christine Robinson; Jacquelyn A Campbell; Sean M O'Donnell; Tibor Valyi-Nagy; Penny Clarke; J Denise Wetzel; Terence S Dermody
Journal:  J Infect Dis       Date:  2004-04-15       Impact factor: 5.226

7.  Structure-function analysis of reovirus binding to junctional adhesion molecule 1. Implications for the mechanism of reovirus attachment.

Authors:  J Craig Forrest; Jacquelyn A Campbell; Pierre Schelling; Thilo Stehle; Terence S Dermody
Journal:  J Biol Chem       Date:  2003-09-09       Impact factor: 5.157

8.  Pathogenesis of reovirus type 1 hydrocephalus in mice. Significance of aqueductal changes.

Authors:  C Masters; M Alpers; B Kakulas
Journal:  Arch Neurol       Date:  1977-01

9.  Human junction adhesion molecule regulates tight junction resealing in epithelia.

Authors:  Y Liu; A Nusrat; F J Schnell; T A Reaves; S Walsh; M Pochet; C A Parkos
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285

10.  Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus.

Authors:  Eric D Laing; Chanakha K Navaratnarajah; Sofia Cheliout Da Silva; Stephanie R Petzing; Yan Xu; Spencer L Sterling; Glenn A Marsh; Lin-Fa Wang; Moushimi Amaya; Dimitar B Nikolov; Roberto Cattaneo; Christopher C Broder; Kai Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.